期刊文献+

HIV Vaccine-Challenges and Opportunities

HIV Vaccine-Challenges and Opportunities
下载PDF
导出
摘要 The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews the neutralizing antibody problem,elusive immune protection,im-munogen design,pre-existing anti-vector immunity and design of phase 3 vaccine trials and the challenges and opportunities in development of HIV/AIDS vaccine are discussed. The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews the neutralizing antibody problem, elusive immune protection, immunogen design, pre-existing anti-vector immunity and design of phase 3 vaccine trials and the challenges and opportunities in development of HIV/AIDS vaccine are discussed .
出处 《Virologica Sinica》 SCIE CAS CSCD 2007年第6期486-492,共7页 中国病毒学(英文版)
基金 National High Technology Research and Development Program of China(2005AAZ18040)
关键词 Neutralizing antibody Cellular immune Protective immunity IMMUNOGEN Efficacy studies 中国 艾滋病 艾滋病病毒 疫苗 中和抗体 细胞免疫 免疫保护力
  • 相关文献

参考文献21

  • 1[1]Barouch D H,Nabel G J.2005.Adenovirus vector-based vaccines for human immunodeficiency virus type 1.Hum Gene Ther,16 (2):149-156.
  • 2[2]Burton D R,Desrosiers R C,Doms R W,et al.2004.HIV vaccine design and the neutralizing antibody problem.Nat Immunol,5 (3):233-236.
  • 3[3]Egan M A,Megati S.2006.Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice.Vaccine,24(21):4510-4523.
  • 4[4]Garber D A,Silvestri G,Feinberg M B.2004.Prospects for an AIDS vaccine:three big questions,no easy answers.Lancet Infect Dis,4 (7):397-413.
  • 5[5]Girard M P,Osmanov S K,Kieny M P.2006.A review of vaccine research and development:the human immunodeficiency virus (HIV).Vaccine,24 (19):4062-4081.
  • 6[6]Koff W C,Johnson P R,Watkins D I.2006.HIV vaccine design:insights from live attenuated SIV vaccines.Nat Immunol,7 (1):19-23
  • 7[7]Hinkula J.2007.Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Expert Rev Vaccines,6 (2):203-212
  • 8[8]Johnston M I,Fauci A S.2007.An HIV vaccine-evolving concepts.N Engl J Med,356 (20):2073-2081.
  • 9[9]Kim D,Elizaga M,Duerr A.2007.HIV vaccine efficacy trials:towards the future of HIV prevention.Infect Dis Clin North Am,21 (1):201-217.
  • 10[10]Koff W C,Johnson P R,Watkins D I,2006.HIV vaccine design:insights from live attenuated SIV vaccines.Nat Immunol,7 (1):19-23.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部